The Influence of Real-Time Continuous Glucose Monitoring on Psychosocial Outcomes in Insulin-Using Type 2 Diabetes
Authors' conclusion
Introduction of rtCGM in adults with insulin-using T2D was associated with significant improvements in diabetes-related psychosocial outcomes over six months. Gains were significantly greater among participants reporting IAH and those with higher HbA1c at baseline, thus providing the first evidence regarding which users might more likely benefit.
Study context
- Population
- Insulin-using adults with T2D; 57.5% male, 67.8% non-Hispanic white
- Participants
- 174 adults
- Comparison
- Psychosocial outcomes before vs after 6 months of real-time continuous glucose monitoring (rtCGM)
- Outcome
- Change in diabetes distress, hypoglycemic confidence, hypoglycemic fear, device-related emotional burden and device-related trust
- Follow-up
- 6 months
Methodological detailssix-month trial of rtCGM
- Six-month trial of rtCGM
Main finding
As reported in the abstract
Change in psychosocial outcomes over the trial
- Significant improvement in hypoglycemic fear
- P = .031
- Significant improvement in hypoglycemic confidence
- P < .001
- Significant improvement in diabetes distress
- P < .001
- Significant improvement in device-related emotional burden
- P < .001
Further findings
Baseline IAH as predictor of improvement
- IAH predicted greater improvement in hypoglycemic fear
- P = 0.002
- IAH predicted greater improvement in hypoglycemic confidence
- P = 0.003
- IAH predicted greater improvement in diabetes distress
- P = 0.013
- IAH predicted greater improvement in device-related emotional burden
- P < 0.001
Hemoglobin A1c (HbA1c) as predictor of change
- Higher baseline HbA1c linked with greater improvement in hypoglycemic fear
- P = 0.030
- HbA1c change positively associated with change in diabetes distress
- P = 0.010
- HbA1c change positively associated with change in device-related emotional burden
- P = 0.003
Original publication
The Influence of Real-Time Continuous Glucose Monitoring on Psychosocial Outcomes in Insulin-Using Type 2 Diabetes. J Diabetes Sci Technol. Published 9 May 2022. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →